Form 4 for HHS HARTE HANKS INC

Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-13 · accession 0001437749-22-014936 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-14	2022-06-13	HHS	KEARNES LAURILEE	CFO	M - OptEx	—	+13.2K	109.8K	+14%	—
D	2022-06-14	2022-06-13	HHS	KEARNES LAURILEE	CFO	F - Tax	$10.84	-5,178	104.6K	-5%	-$56.1K
D	2022-06-14	2022-06-13	HHS	KEARNES LAURILEE	CFO	M - OptEx	$0.00	-13.2K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-13	M	A	13,158	—	109,821	D	—	—	(F1) Performance-based Stock Units ("PSU") convert into Common Stock on a one-for-one basis.
2	Common	Common Stock	2022-06-13	F	D	5,178	$10.84	104,643	D	—	—	(F2) Represents shares withheld to offset the reporting person's tax obligations upon vesting of the Performance-based Stock Units.
3	Derivative	Performance-based Stock Units	2022-06-13	M	D	13,158	$0.00	0	D	— · — to —	13,158 Common Stock	(F1) Performance-based Stock Units ("PSU") convert into Common Stock on a one-for-one basis. (F3) On September 6, 2019, the reporting person was granted 13,158 Performance-based Stock Units, which will vest on the later of (i) the first anniversary of the grant date and (ii) the first business day following the date on which the Company's common stock price reaches $8.00 and remains at or above such price for a consecutive 30-day period, subject to reporting person's employment on the applicable vesting date.